Search Browse Earnings

ICAD INC

Surgical & Medical Instruments & Apparatus·NASHUA, NH

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

ICAD INC — SlamSEC

Revenue

$17.3M

-12.5% YoY

FY 2024

Adj. EBITDA

-$7.4M

-43.0% margin

FY 2024

Net Income

-$4.8M

-28.0% margin

FY 2024

EPS (Diluted)

-$0.80

FY 2022

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$21.7M

FY 2024

Total Debt

$11.2M

FY 2021

Net Cash

$10.5M

FY 2021

Enterprise Value

—

Debt / EBITDA

1.4x

FY 2024

EV / EBITDA

—

Employees

—